Monkeypox

WHO lists 2 more mpox tests under its emergency use procedure
By LabPulse.com staff writers
The World Health Organization (WHO) has listed two additional IVD tests under its emergency use listing procedure.
October 30, 2024
Monkeypox Virus Social
WHO approves Abbott mpox test for emergency use
By LabPulse.com staff writers
The World Health Organization (WHO) authorized Abbott Laboratories' mpox diagnostic test under its emergency use listing procedure, the first such approval by the agency in its effort to expand the diagnostic capacity of countries facing mpox outbreaks.
October 4, 2024
3 D Monkeypox Infecting Cell Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
CDC prioritizes mpox specimens for testing laboratories
By LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Monkeypox Virus Social
Seegene develops two RUO mpox assays
By LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
Monkeypox Virus Social
Roche announces support for mpox response
By LabPulse.com staff writers
Roche is supporting the response to the global mpox health emergency by providing increased access to polymerase chain reaction (PCR) testing and partnering with governments, healthcare providers, and organizations to combat the mpox outbreak.
August 21, 2024
Monkeypox Virus Social
CDC, WHO update on mpox outbreak
By LabPulse.com staff writers
The Centers for Disease Control and Prevention (CDC) recommended clinicians and jurisdictions in the U.S. maintain a heightened index of suspicion for monkeypox (mpox).
August 14, 2024
CDC mpox data, cases reported to the CDC as of August 1, 2024. (Source: U.S. CDC)
Siga Technologies, HHS sign $113M procurement deal for smallpox, mpox treatment
By LabPulse.com staff writers
Biotech company Siga Technologies announced that the U.S. Department of Health and Human Services (HHS) exercised a procurement option on an existing contract with Siga to deliver approximately $113 million of the firm's oral antiviral treatment TPoxx.
July 22, 2024
3 D Monkeypox Infecting Cell Social
CRISPR and nanopore technology enable sensitive and specific mpox detection
By Nick Paul Taylor
A test that combines CRISPR gene editing and nanopore sensing technology could accelerate the detection of mpox and other pathogens, according to a paper published in Biosensors and Bioelectronics.
February 16, 2024
3 D Monkeypox Infecting Cell Social
Cue Health receives FDA emergency use authorization for molecular mpox test
By Leo O'Connor
The test demonstrated high accuracy in clinical trials, achieving 100% concordance with the Center for Disease Control and Prevention’s (CDC's) mpox test on the samples tested, Cue Health said.
March 20, 2023
Monkeypox Virus Social
Discovery of severe form of mpox spurs call for update to list of AIDS-defining diseases
By Nick Paul Taylor
Analyses of cases in earlier outbreaks of mpox, the viral disease formerly known as monkeypox, and of a small number of patients infected in the current multi-country outbreak suggested that people with advanced HIV may suffer more severe infections.
February 22, 2023
3 D Monkeypox Infecting Cell Social
Thermo Fisher Scientific obtains FDA EUA for monkeypox/orthopox virus DNA kit
By LabPulse.com staff writers
The test is intended for the qualitative detection of DNA from monkeypox virus (clade I/II) and screening for non-variola orthopoxviruses in human lesion swab specimens.
December 15, 2022
3 D Monkeypox Infecting Cell Social
Page 1 of 2
Next Page